Caricamento...
Therapeutic management of hyperlipoproteinemia (a)
Cardiovascular disease (CVD) has consistently been the leading cause of death worldwide. Several clinical and epidemiological studies have demonstrated that an elevated plasma concentration of lipoprotein (a) [Lp(a)] is a causative and independent major risk factor for the development of CVD, as wel...
Salvato in:
| Pubblicato in: | Drugs Context |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioExcel Publishing Ltd
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6752750/ https://ncbi.nlm.nih.gov/pubmed/31555339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212609 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|